Paccasassi Robert 4
4 · BioRestorative Therapies, Inc. · Filed Nov 4, 2022
Insider Transaction Report
Form 4
Paccasassi Robert
VP, Quality and Compliance
Transactions
- Disposition to Issuer
Stock Option
2022-11-03−8,277→ 0 totalExercise: $13.50Exp: 2031-11-04→ Common Stock (8,277 underlying) - Award
Stock Option
2022-11-03+8,277→ 8,277 totalExercise: $5.08Exp: 2031-11-04→ Common Stock (8,277 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
- [F2]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option with a reduced exercise price.